Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response.
Parker C, Tunariu N, Tovey H, Alonzi R, Blackledge MD, Cook GJR, Chua S, Du Y, Hafeez S, Murray I, Padhani AR, Staffurth J, Tree A, Stidwill H, Finch J, Curcean A, Chatfield P, Perry S, Koh DM, Hall E. Parker C, et al. Among authors: alonzi r. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad077. doi: 10.1093/jncics/pkad077. JNCI Cancer Spectr. 2023. PMID: 37788117 Free PMC article. Clinical Trial.
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223.
Hijab A, Curcean S, Tunariu N, Tovey H, Alonzi R, Staffurth J, Blackledge M, Padhani A, Tree A, Stidwill H, Finch J, Chatfield P, Perry S, Mu Koh D, Hall E, Parker C. Hijab A, et al. Among authors: alonzi r. Clin Genitourin Cancer. 2021 Oct;19(5):e299-e305. doi: 10.1016/j.clgc.2021.03.020. Epub 2021 Apr 4. Clin Genitourin Cancer. 2021. PMID: 33958296 Free PMC article. Clinical Trial.
Dynamic contrast enhanced MRI in prostate cancer.
Alonzi R, Padhani AR, Allen C. Alonzi R, et al. Eur J Radiol. 2007 Sep;63(3):335-50. doi: 10.1016/j.ejrad.2007.06.028. Epub 2007 Aug 8. Eur J Radiol. 2007. PMID: 17689907 Review.
UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer.
Barnes A, Alonzi R, Blackledge M, Charles-Edwards G, Collins DJ, Cook G, Coutts G, Goh V, Graves M, Kelly C, Koh DM, McCallum H, Miquel ME, O'Connor J, Padhani A, Pearson R, Priest A, Rockall A, Stirling J, Taylor S, Tunariu N, van der Meulen J, Walls D, Winfield J, Punwani S. Barnes A, et al. Among authors: alonzi r. Br J Radiol. 2018 Jan;91(1081):20170577. doi: 10.1259/bjr.20170577. Epub 2017 Dec 7. Br J Radiol. 2018. PMID: 29076749 Free PMC article.
Changes in Magnetic Resonance Imaging Radiomic Features in Response to Androgen Deprivation Therapy in Patients with Intermediate- and High-risk Prostate Cancer.
Tharmalingam H, Tsang YM, Alonzi R, Beasley W, Taylor NJ, McWilliam A, Padhani A, Choudhury A, Hoskin PJ. Tharmalingam H, et al. Among authors: alonzi r. Clin Oncol (R Coll Radiol). 2022 Jun;34(6):e246-e253. doi: 10.1016/j.clon.2021.12.020. Epub 2022 Jan 13. Clin Oncol (R Coll Radiol). 2022. PMID: 35033410
Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck.
Ng QS, Mandeville H, Goh V, Alonzi R, Milner J, Carnell D, Meer K, Padhani AR, Saunders MI, Hoskin PJ. Ng QS, et al. Among authors: alonzi r. Ann Oncol. 2012 Jan;23(1):231-237. doi: 10.1093/annonc/mdr332. Epub 2011 Jul 15. Ann Oncol. 2012. PMID: 21765046 Free article. Clinical Trial.
46 results